LY-3130481

N/A

Report date: 2025/05/29 20:00:08
NME

Base Information

Drug NameLY-3130481
Drug Alias NameLY-3130481CERC-611(-)-25 LY3130481ES-481
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA antagonistsVoltage-gated calcium channel blockers
TargetsGlutamate receptor ionotropic AMPAVoltage-gated calcium channel
Therapy Area/IndicationsSeizuresDrug Resistant EpilepsyEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesCerecorES Therapeutics Australia Pty Ltd
Inactive CompaniesEli Lilly And Company
Active IndicationsDrug Resistant Epilepsy
Inactive IndicationsSeizuresEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A